GLENOHUMERAL OSTEOARTHRITIS
Clinical trials for GLENOHUMERAL OSTEOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLENOHUMERAL OSTEOARTHRITIS trials appear
Sign up with your email to follow new studies for GLENOHUMERAL OSTEOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shoulder implant study aims to improve joint replacement outcomes
Disease control Recruiting nowThis study compares two types of shoulder implants for people with shoulder osteoarthritis who need a total shoulder replacement. About 94 participants will be randomly assigned to receive either a standard cemented plastic implant or a newer hybrid metal-and-plastic implant. The…
Matched conditions: GLENOHUMERAL OSTEOARTHRITIS
Phase: NA • Sponsor: Spaarne Gasthuis • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
10-Year shoulder implant study launches to track Long-Term success
Disease control Recruiting nowThis study follows 1,004 people who receive an FX Shoulder Solutions shoulder replacement for up to 10 years. The main goal is to see how often the implant needs to be replaced or revised over time. Researchers will also measure shoulder movement, pain, and daily function using s…
Matched conditions: GLENOHUMERAL OSTEOARTHRITIS
Sponsor: FX Solutions • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
New shot aims to ease shoulder arthritis pain
Symptom relief Recruiting nowThis study tests if an injection called ZILRETTA can reduce pain in people with shoulder osteoarthritis. About 150 adults aged 50 to 80 will receive either ZILRETTA, a standard steroid, or a placebo. The main goal is to see if ZILRETTA improves daily pain scores after 12 weeks.
Matched conditions: GLENOHUMERAL OSTEOARTHRITIS
Phase: PHASE3 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated May 26, 2026 04:31 UTC